Heart Failure Clinical Trial
The Inotrope Evaluation and Research Patient Registry
Summary
The INTERPRET Inotrope Evaluation and Research Patient Registry is a longitudinal, observational study designed to look at the demographics and outcomes of heart failure patients on inotropic therapy administered in the home or infusion suite setting. The data gathered in this registry will provide information on how a patient's quality of life and symptoms change over time while on inotrope therapy, and help healthcare providers to have a better understanding of the benefits and risks associated with bridge-to-treatment and palliative care.
Full Description
Eligible patients will be consented by the site investigator or staff to participate in the Registry at the time of referral for home care. Clinical data, including dosing, symptom severity, lab values, and hospitalizations, along with data on quality-of-life and patient compliance with treatment, will be collected by the home care nurses and pharmacists. The Registry's goal is to significantly contribute to the medical understandings of heart failure treatment and to improve the quality of care for heart failure patients in the United States through active publication of registry findings and disease management approaches.
Eligibility Criteria
Inclusion Criteria:
Patient must be prescribed inotropic treatment (milrinone, dobutamine or dopamine)
Patient must be referred to Coram for this treatment in an alternate site of care, either home or infusion suite
Patient must be willing to receive care and comply with the teaching and training necessary to administer treatment
Patient is age 18 or over
Exclusion Criteria:
Patient is unable to start, or stops taking, inotropic medication
Patient and/or patient insurance will not cover cost of home inotropic treatment with Coram, or patient elects not to start treatment
Patient is under the age of 18
Check Your Eligibility
Let’s see if you might be eligible for this study.
What is your age and gender ?
There are 5 Locations for this study
Birmingham Alabama, 35294, United States
Chicago Illinois, 60611, United States
Kansas City Kansas, 66160, United States
New York New York, 10029, United States
New York New York, 10032, United States
How clear is this clinincal trial information?

Please confirm you are a US based health care provider:
Yes, I am a health care Provider No, I am not a health care providerSign Up Now.
Take Control of Your Disease Journey.
Sign up now for expert patient guides, personalized treatment options, and cutting-edge insights that can help you push for the best care plan.